14-76498312-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001379180.1(ESRRB):​c.1219C>T​(p.Pro407Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0703 in 1,613,184 control chromosomes in the GnomAD database, including 4,390 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.062 ( 357 hom., cov: 32)
Exomes 𝑓: 0.071 ( 4033 hom. )

Consequence

ESRRB
NM_001379180.1 missense

Scores

1
8
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 7.91

Publications

20 publications found
Variant links:
Genes affected
ESRRB (HGNC:3473): (estrogen related receptor beta) This gene encodes a protein with similarity to the estrogen receptor. Its function is unknown; however, a similar protein in mouse plays an essential role in placental development. [provided by RefSeq, Jul 2008]
ESRRB Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 35
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005125433).
BP6
Variant 14-76498312-C-T is Benign according to our data. Variant chr14-76498312-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 44995.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ESRRBNM_001379180.1 linkc.1219C>T p.Pro407Ser missense_variant Exon 7 of 7 ENST00000644823.1 NP_001366109.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ESRRBENST00000644823.1 linkc.1219C>T p.Pro407Ser missense_variant Exon 7 of 7 NM_001379180.1 ENSP00000493776.1

Frequencies

GnomAD3 genomes
AF:
0.0616
AC:
9371
AN:
152182
Hom.:
357
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0244
Gnomad AMI
AF:
0.0724
Gnomad AMR
AF:
0.129
Gnomad ASJ
AF:
0.0504
Gnomad EAS
AF:
0.101
Gnomad SAS
AF:
0.0704
Gnomad FIN
AF:
0.0488
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0680
Gnomad OTH
AF:
0.0659
GnomAD2 exomes
AF:
0.0766
AC:
18998
AN:
248148
AF XY:
0.0742
show subpopulations
Gnomad AFR exome
AF:
0.0228
Gnomad AMR exome
AF:
0.136
Gnomad ASJ exome
AF:
0.0532
Gnomad EAS exome
AF:
0.110
Gnomad FIN exome
AF:
0.0507
Gnomad NFE exome
AF:
0.0692
Gnomad OTH exome
AF:
0.0753
GnomAD4 exome
AF:
0.0712
AC:
104043
AN:
1460884
Hom.:
4033
Cov.:
35
AF XY:
0.0709
AC XY:
51493
AN XY:
726768
show subpopulations
African (AFR)
AF:
0.0215
AC:
718
AN:
33472
American (AMR)
AF:
0.136
AC:
6086
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
0.0565
AC:
1477
AN:
26122
East Asian (EAS)
AF:
0.0961
AC:
3813
AN:
39668
South Asian (SAS)
AF:
0.0679
AC:
5853
AN:
86246
European-Finnish (FIN)
AF:
0.0527
AC:
2788
AN:
52874
Middle Eastern (MID)
AF:
0.0539
AC:
311
AN:
5766
European-Non Finnish (NFE)
AF:
0.0708
AC:
78734
AN:
1111786
Other (OTH)
AF:
0.0706
AC:
4263
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
6137
12273
18410
24546
30683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3004
6008
9012
12016
15020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0615
AC:
9372
AN:
152300
Hom.:
357
Cov.:
32
AF XY:
0.0645
AC XY:
4806
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.0243
AC:
1012
AN:
41584
American (AMR)
AF:
0.129
AC:
1969
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0504
AC:
175
AN:
3472
East Asian (EAS)
AF:
0.101
AC:
521
AN:
5164
South Asian (SAS)
AF:
0.0705
AC:
340
AN:
4826
European-Finnish (FIN)
AF:
0.0488
AC:
518
AN:
10614
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0680
AC:
4623
AN:
68014
Other (OTH)
AF:
0.0652
AC:
138
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
461
921
1382
1842
2303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0637
Hom.:
741
Bravo
AF:
0.0637
TwinsUK
AF:
0.0763
AC:
283
ALSPAC
AF:
0.0747
AC:
288
ESP6500AA
AF:
0.0252
AC:
111
ESP6500EA
AF:
0.0680
AC:
585
ExAC
AF:
0.0712
AC:
8643
Asia WGS
AF:
0.108
AC:
375
AN:
3478
EpiCase
AF:
0.0677
EpiControl
AF:
0.0715

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pro386Ser in Exon 09 of ESRRB: This variant is not expected to have clinical sig nificance because it has been identified in 6.9% (481/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs35774316). -

not provided Benign:3
Sep 12, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 35 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
0.080
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.64
D;.;.;.
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.84
T;.;T;T
MetaRNN
Benign
0.0051
T;T;T;T
MetaSVM
Benign
-0.49
T
MutationAssessor
Benign
1.4
.;L;.;L
PhyloP100
7.9
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-2.4
N;N;.;N
REVEL
Pathogenic
0.68
Sift
Benign
0.45
T;T;.;T
Sift4G
Benign
0.72
.;T;.;T
Polyphen
0.60
P;.;.;.
Vest4
0.34, 0.32
MPC
0.60
ClinPred
0.026
T
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.55
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61742642; hg19: chr14-76964655; COSMIC: COSV107224640; COSMIC: COSV107224640; API